Valomaciclovir: Phase IIb started

Epiphany began a Phase IIb trial to compare once-daily valomaciclovir vs. thrice-daily Valtrex valacyclovir from GlaxoSmithKline plc (LSE:GSK; GSK, London, U.K.). Medivir granted Epiphany worldwide ...